ADMS Performance At-A-Glance
Adamas Pharmaceuticals Inc's risk efficiency is 1.63, which is good. By comparison, the S&P500 is -0.43.
Increasing quickly over the past 4 weeks.
Adamas Pharmaceuticals Inc's dScore is 5.47% , which is more volatile than the S&P500 (2.74%).
Adamas Pharmaceuticals Inc has grown by 91.16% over the past year. By comparison, the S&P500 has lost -11.31%.
Remained steady over the past 4 weeks.